About: http://data.cimple.eu/news-article/90bee22ab6a251c7cbae3f50c7feb2fd5e4d05892443457fcea57e12

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/90bee22ab6a251c7cbae3f50c7feb2fd5e4d05892443457fcea57e12 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swedish health officials on Tuesday recommended that the newly approved AstraZeneca Covid-19 vaccine primarily be used for those under the age of 65, citing a lack of evidence for its efficacy among the elderly. The country's Public Health Agency (FHM) said the British-Swedish pharma giant's vaccine should "firstly" be offered to people between 18 and 65 years old. Conversely, previously approved vaccines from Pfizer/BioNTech and Moderna should primarily be offered to people 65 and over. The move follows other countries, such as Germany and Italy, which have also advised that other vaccines be prioritised for the elderly, even though the AstraZeneca vaccine was approved by the European Medicines Agency (EMA) for all ages last week. FHM noted that the EMA had signalled a lack of evidence to document efficacy of the vaccine among elderly. "However, there is nothing that says that it doesn't have a protective effect or that it would have any negative effects in those age groups," Soren Andersson, head of the unit for vaccination programmes at FHM, told a press conference. Andersson said the change in priorities would mean a temporary delay in the rollout of Sweden's Covid-19 vaccination programme, but also noted there were more vaccine candidates coming up and large volumes being shipped to Sweden. "It's a partial shortage, but there are vaccines and we'll have to make sure they are used in the most effective way," Andersson said. Sweden, a country of 10.3 million, began vaccinations on December 27 and so far 256,978 people have received the first dose. The country also announced that randomised testing had shown that the mutated variant first discovered in the UK, believed to be more infectious, seemed to have become more prevalent. Out of 2,220 positive Covid-19 tests screened, the UK variant had been discovered in 250 samples. jll/po/spm
schema:headline	Sweden targets AstraZeneca Covid-19 jab for under 65s
schema:mentions	European Medicines Agency Jab Sweden AstraZeneca Germany Italy Pfizer United Kingdom Vaccine Coronavirus disease 2019 FHM Benny Andersson JLL (company) The Move
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-02 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	80 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software